• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Petco Health + Wellness Company, Inc. Reports Third Quarter Earnings

    11/29/23 7:00:00 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary
    Get the next $WOOF alert in real time by email

    Q3 2023 Operating Results

    • Comparable sales flat year-over-year and increased 4.1 percent on a two-year basis
    • Net revenue of $1.49 billion decreased 0.5 percent year-over-year
    • GAAP net loss of $1.2 billion, or $(4.63) per share, reflecting a $1.2 billion non-cash goodwill impairment charge associated with goodwill originally recorded in 2015, compared to GAAP net income of $19.9 million, or $0.07 per share in the prior year
    • Adjusted Net Income1 decreased $44.5 million to $(14.5) million
    • Adjusted EBITDA1 of $72.2 million compared to $120.2 million in the prior year
    • Adjusted Earnings Per Share1 of $(0.05), compared to $0.11 per share in the prior year
    • Operating Cash Flow of $34.4 million compared to $109.4 million in the prior year
    • Free Cash Flow1 of $(28.1) million, compared to $33.5 million in the prior year and $(7.8) million compared to $(2.6) million in the prior year on a year-to-date basis

    SAN DIEGO, Nov. 29, 2023 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), a complete partner in pet health and wellness, today announced its third quarter 2023 financial results.

    Petco (PRNewsFoto/Petco)

    In the third quarter of 2023, Petco delivered net revenue of $1.49 billion, down 0.5 percent versus prior year. The company's consumables business was up 1.8 percent versus prior year, and services and other business was up 15.0 percent versus prior year. Growth in the company's consumables and services and other business was partially offset by the company's supplies and companion animal business, down 8.8 percent versus prior year. 

    During the third quarter, Petco recorded a $1.2 billion non-cash goodwill impairment charge associated with goodwill originally recorded in fiscal 2015, and due to decline in the company's stock price. This drove a GAAP net loss of $1.2 billion or $(4.63) per share compared to GAAP net income of $19.9 million or $0.07 per share in the prior year. Included in Q3 EPS is $0.03 of incremental interest expense year-over-year.

    "Our third quarter results were below our expectations as we continue to navigate a challenging consumer environment and we are taking swift and decisive action to improve the performance of our business by broadening our appeal with customers and tightly managing costs and capital. This includes the introduction of the category's largest national cat and dog food value brands to meet the needs of all pet parents and deliver incremental profits over time," said Petco CEO Ron Coughlin. "We're confident these actions, combined with continued growth in services, omni-channel capabilities, an industry-leading premium assortment, and dedicated Petco partners will better position us to capture the long-term growth trends in the category and deepen our connection with all pet parents."

    As previously disclosed, in the third quarter of 2023, Petco paid down $15 million in principal on its term loan for a total of $75 million in principal payments year-to-date.

    On the earnings conference call, management will also outline an operational reset of the business, focusing on increasing profitability and competitive positioning. This will include an update on the cost action plan outlined in Q2, as part of targeting annualized gross run rate cost savings of $150 million by the end of fiscal 2025, from merchandise, supply chain, and general G&A categories. The company continues to expect to achieve $40 million in savings in year one.

    (1)

    Adjusted EBITDA, Adjusted Net Income, Adjusted Earnings Per Share ("Adjusted EPS"), and Free Cash Flow are non-GAAP financial measures. See "Non-GAAP Financial Measures" for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

    Fiscal 2023 Guidance

    The company is updating its fiscal 2023 guidance for Adjusted EBITDA and Adjusted EPS and now expects:

    Metric*

    2023 Guidance

    Net Revenue

    $6.150 billion to $6.275 billion

    Adjusted EBITDA

    approximately $400 million 

    Adjusted EPS

    approximately $0.08

    Capital Expenditures

    $215 million to $225 million

     

    *Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent. Adjusted EPS guidance assumes approximately $145 to $155 million of interest expense, an estimated $43 to $53 million increase in interest expense year-over-year, a 26 percent tax rate, and a 268 million weighted average diluted share count (prior guidance assumed a 269 million weighted average diluted share count). The Company estimates that the increase in interest expense will impact Adjusted EPS by approximately $0.12 to $0.15 per share.  Furthermore, Fiscal 2023 will be a 53-week year, leading to an incremental week of operations.  Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures and have not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA and Adjusted EPS are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the Securities and Exchange Commission.

    Earnings Conference Call Webcast Information:

    Management will host an earnings conference call on November 29, 2023 at 8:00 AM Eastern Time to discuss the company's financial results.  The conference call will be accessible through a live webcast. Interested investors and other individuals can access the webcast, earnings release, earnings presentation, and infographic via the company's investor relations page at ir.petco.com. A replay of the webcast will be archived on the company's investor relations page through December 13, 2023 until approximately 5:00PM Eastern Time.

    About Petco, The Health + Wellness Co.:

    Founded in 1965, Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. We've consistently set new standards in pet care while delivering comprehensive pet wellness products, services and solutions, and creating communities that deepen the pet-pet parent bond. We operate more than 1,500 pet care centers across the U.S., Mexico and Puerto Rico, which offer merchandise, companion animals, grooming, training and a growing network of on-site veterinary hospitals and mobile veterinary clinics. Our complete pet health and wellness ecosystem is accessible through our pet care centers and digitally at petco.com and on the Petco app. In tandem with Petco Love, a life-changing organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we've helped find homes for nearly 7 million animals.

    Forward-Looking Statements:

    This earnings release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact, including, but not limited to, statements regarding our fiscal year 2023 guidance, operational reset of our business, our competitive positioning, profitability, cost action plans and associated cost-savings. Such forward-looking statements can generally be identified by the use of forward-looking terms such as "believes," "expects," "may," "intends," "will," "shall," "should," "anticipates," "opportunity," "illustrative," or the negative thereof or other variations thereon or comparable terminology. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct or that any forward-looking results will occur or be realized. Nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of Petco. All forward-looking statements are based on current expectations and assumptions about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Petco. Forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results or events to differ materially from the potential results or events discussed in the forward-looking statements, including, without limitation, those identified in this earnings release as well as the following: (i) increased competition (including from multi-channel retailers and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate, including inflation and prevailing interest rates; (vii) failure to effectively manage our costs; (viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a data privacy or security breach; (x) our ability to effectively manage or integrate strategic ventures, alliances or acquisitions and realize the anticipated benefits of such transactions; (xi) economic or regulatory developments that might affect our ability to provide attractive promotional financing; (xii) business interruptions and other supply chain issues; (xiii) catastrophic events, political tensions, conflicts and wars (such as the ongoing conflict in Ukraine), health crises, and pandemics; (xiv) our ability to maintain positive brand perception and recognition; (xv) product safety and quality concerns; (xvi) changes to labor or employment laws or regulations; (xvii) our ability to effectively manage our real estate portfolio; (xviii) constraints in the capital markets or our vendor credit terms; (xix) changes in our credit ratings; (xx) impairments of the carrying value of our goodwill and other intangible assets; (xxi) our ability to successfully implement our operational adjustments, achieve the expected benefits of our cost action plans and drive improved profitability; and (xxii) the other risks, uncertainties and other factors identified under "Risk Factors"  and elsewhere in Petco's Securities and Exchange Commission filings. The occurrence of any such factors could significantly alter the results set forth in these statements.

    Petco cautions that the foregoing list of risks, uncertainties and other factors is not complete, and forward-looking statements speak only as of the date they are made. Petco undertakes no duty to update publicly any such forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.

     

    PETCO HEALTH AND WELLNESS COMPANY, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except per share amounts)

    (Unaudited and subject to reclassification)



















    13 Weeks Ended





    October 28,

    2023



    October 29,

    2022



    Percent

    Change

    Net sales:













    Products



    $   1,257,803



    $ 1,295,771



    (3 %)

    Services and other



    236,363



    205,449



    15 %

    Total net sales



    1,494,166



    1,501,220



    (0 %)

    Cost of sales:













    Products



    787,994



    759,303



    4 %

    Services and other



    156,171



    144,240



    8 %

    Total cost of sales



    944,165



    903,543



    4 %

    Gross profit



    550,001



    597,677



    (8 %)

    Selling, general and administrative expenses



    559,611



    549,622



    2 %

    Goodwill impairment



    1,222,524



    —



    N/M

    Operating (loss) income



    (1,232,134)



    48,055



    N/M

    Interest income



    (1,139)



    (130)



    776 %

    Interest expense



    36,557



    27,307



    34 %

    Loss on partial extinguishment of debt



    174



    —



    N/M

    Other non-operating (income) loss



    (113)



    (576)



    (80 %)

    (Loss) income before income taxes and income from

       equity method investees



    (1,267,613)



    21,454



    N/M

    Income tax (benefit) expense



    (22,902)



    4,161



    N/M

    Income from equity method investees



    (3,574)



    (2,627)



    36 %

    Net (loss) income



    (1,241,137)



    19,920



    N/M

    Net loss attributable to noncontrolling interest



    —



    —



    N/M

    Net (loss) income attributable to Class A and B-1 common

       stockholders



    $  (1,241,137)



    $     19,920



    N/M















    Net (loss) income per Class A and B-1 common share:













    Basic



    $           (4.63)



    $        0.07



    N/M

    Diluted



    $           (4.63)



    $        0.07



    N/M















    Weighted average shares used in computing net (loss) income per Class A

       and B-1 common share:













    Basic



    267,852



    265,689



    1 %

    Diluted



    267,852



    265,935



    1 %

     

    PETCO HEALTH AND WELLNESS COMPANY, INC.

    CONSOLIDATED BALANCE SHEETS

    (In thousands, except per share amounts)

    (Unaudited and subject to reclassification)











     October 28,

    2023 



     January 28,

    2023 

    ASSETS









    Current assets:









    Cash and cash equivalents



    $    139,782



    $   201,901

    Receivables, less allowance for credit losses1



    50,180



    49,580

    Merchandise inventories, net



    730,148



    652,430

    Prepaid expenses



    46,856



    51,274

    Other current assets



    40,562



    60,809

    Total current assets



    1,007,528



    1,015,994

    Fixed assets



    2,142,520



    1,987,560

    Less accumulated depreciation



    (1,314,721)



    (1,184,233)

    Fixed assets, net



    827,799



    803,327

    Operating lease right-of-use assets



    1,390,671



    1,397,761

    Goodwill



    976,247



    2,193,941

    Trade name



    1,025,000



    1,025,000

    Other long-term assets



    199,316



    176,806

    Total assets



    $ 5,426,561



    $ 6,612,829

    LIABILITIES AND EQUITY









    Current liabilities:









    Accounts payable and book overdrafts



    $    486,634



    $   381,213

    Accrued salaries and employee benefits



    100,997



    89,929

    Accrued expenses and other liabilities



    215,875



    217,556

    Current portion of operating lease liabilities



    305,975



    309,766

    Current portion of long-term debt and other lease liabilities



    5,082



    22,794

    Total current liabilities



    1,114,563



    1,021,258

    Senior secured credit facilities, net, excluding current portion



    1,574,909



    1,628,331

    Operating lease liabilities, excluding current portion



    1,148,958



    1,148,155

    Deferred taxes, net



    270,841



    303,121

    Other long-term liabilities



    124,436



    130,487

    Total liabilities



    4,233,707



    4,231,352

    Commitments and contingencies









    Stockholders' equity:









    Class A common stock2



    230



    228

    Class B-1 common stock3



    38



    38

    Class B-2 common stock4



    —



    —

    Preferred stock5



    —



    —

    Additional paid-in-capital



    2,212,713



    2,152,342

    (Accumulated deficit) retained earnings



    (1,024,667)



    232,967

    Accumulated other comprehensive income (loss)



    4,540



    (4,098)

    Total stockholders' equity



    1,192,854



    2,381,477

    Total liabilities and stockholders' equity



    $ 5,426,561



    $ 6,612,829





    (1)

    Allowances for credit losses are $1,897 and $952, respectively

    (2)

    Class A common stock, $0.001 par value: Authorized - 1.0 billion shares; Issued and outstanding - 230.3 million and 228.3 million shares, respectively

    (3)

    Class B-1 common stock, $0.001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

    (4)

    Class B-2 common stock, $0.000001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

    (5)

    Preferred stock, $0.001 par value: Authorized - 25.0 million shares; Issued and outstanding - none

     

    PETCO HEALTH AND WELLNESS COMPANY, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited and subject to reclassification)















    39 Weeks Ended





    October 28,

    2023



    October 29,

    2022

    Cash flows from operating activities:









    Net (loss) income



    $(1,257,635)



    $     57,178

    Adjustments to reconcile net (loss) income to net cash provided by

      operating activities:









    Depreciation and amortization



    148,593



    143,599

    Amortization of debt discounts and issuance costs



    3,658



    3,694

    Provision for deferred taxes



    (35,164)



    (6,413)

    Equity-based compensation



    64,431



    40,892

    Impairments, write-offs and losses on sale of fixed and other assets



    2,202



    2,299

    Loss on partial extinguishment of debt



    920



    —

    Amounts reclassified out of accumulated other comprehensive income (loss)



    674



    —

    Income from equity method investees



    (10,032)



    (7,821)

    Goodwill impairment



    1,222,524



    —

    Non-cash operating lease costs



    316,355



    316,492

    Other non-operating (income) loss



    (4,727)



    9,369

    Changes in assets and liabilities:









    Receivables



    (600)



    9,171

    Merchandise inventories



    (77,718)



    (48,314)

    Prepaid expenses and other assets



    (6,004)



    (2,536)

    Accounts payable and book overdrafts



    105,421



    (19,381)

    Accrued salaries and employee benefits



    11,586



    (16,160)

    Accrued expenses and other liabilities



    (1,098)



    12,110

    Operating lease liabilities



    (312,935)



    (282,954)

    Other long-term liabilities



    (1,755)



    (1,762)

        Net cash provided by operating activities



    168,696



    209,463

    Cash flows from investing activities:









    Cash paid for fixed assets



    (176,532)



    (212,074)

    Cash paid for acquisitions, net of cash acquired



    (4,495)



    (7,750)

    Cash paid for interest in veterinary joint venture



    —



    (35,000)

    Proceeds from investment



    24,878



    —

    Proceeds from sale of assets



    —



    2,127

        Net cash used in investing activities



    (156,149)



    (252,697)

    Cash flows from financing activities:









    Borrowings under long-term debt agreements



    —



    123,000

    Repayments of long-term debt



    (75,000)



    (135,750)

    Payments for finance lease liabilities



    (4,627)



    (4,174)

    Proceeds from employee stock purchase plan and stock option exercises



    3,324



    3,472

    Tax withholdings on stock-based awards



    (7,737)



    (13,581)

        Net cash used in financing activities



    (84,040)



    (27,033)











    Net (decrease) increase in cash, cash equivalents and restricted cash



    (71,493)



    (70,267)

    Cash, cash equivalents and restricted cash at beginning of period



    213,727



    221,890

    Cash, cash equivalents and restricted cash at end of period



    $    142,234



    $    151,623

     

    NON-GAAP FINANCIAL MEASURES

    The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this earnings release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this earnings release. The non-GAAP financial measures in this earnings release may differ from similarly titled measures used by other companies.

    The tables below reflect the calculation of Adjusted EBITDA (include Trailing Twelve Month Adjusted EBITDA), Adjusted Net Income, Adjusted EPS, and Free Cash Flow, for the thirteen weeks ended October 28, 2023, compared to the thirteen weeks ended October 29, 2022 as well as the twelve-month period ended January 28, 2023.

    Adjusted EBITDA and Trailing Twelve Month Adjusted EBITDA

    Adjusted EBITDA, including Trailing Twelve Month Adjusted EBITDA, is considered a non-GAAP financial measure under the Securities and Exchange Commission's (SEC) rules because it excludes certain amounts included in net income calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it facilitates comparison of the current period performance with that of the comparable prior period. In addition, Adjusted EBITDA affords investors a view of what management considers to be Petco's core operating performance as well as the ability to make a more informed assessment of such operating performance as compared with that of the prior period. Please see the company's Annual Report on Form 10-K for the fiscal year ended January 28, 2023 filed with the SEC on March 28, 2023 for additional information on Adjusted EBITDA.

     

    (dollars in thousands)



    13 Weeks Ended

    Reconciliation of Net (Loss) Income Attributable to Class A and B-1

       Common Stockholders to Adjusted EBITDA



    October 28,

    2023



    October 29,

    2022

    Net (loss) income attributable to Class A and B-1 common stockholders



    $  (1,241,137)



    $       19,920

    Add (deduct):









    Interest expense, net



    35,418



    27,177

    Income tax (benefit) expense



    (22,902)



    4,161

    Depreciation and amortization



    50,674



    48,029

    Income from equity method investees



    (3,574)



    (2,627)

    Loss on partial extinguishment of debt



    174



    —

    Goodwill impairment



    1,222,524



    —

    Asset impairments and write offs



    1,167



    930

    Equity-based compensation



    18,183



    15,775

    Other non-operating (income) loss



    (113)



    (576)

    Mexico joint venture EBITDA (1)



    9,189



    7,040

    Acquisition-related integration costs (2)



    —



    1,592

    Other costs (3)



    2,556



    (1,233)

    Adjusted EBITDA



    $        72,159



    $    120,188

    Net sales



    $   1,494,166



    $ 1,501,220

    Net margin (4)



    (83.1 %)



    1.3 %

    Adjusted EBITDA Margin



    4.8 %



    8.0 %

     

    (dollars in thousands)



    Trailing Twelve Months

    Reconciliation of Net (Loss) Income Attributable to Class A and B-1

       Common Stockholders to Adjusted EBITDA



    October 28,

    2023



    January 28,

    2023



    October 29,

    2022

    Net (loss) income attributable to Class A and B-1 common stockholders



    $ (1,224,903)



    $      90,801



    $       87,063

    Add (deduct):













    Interest expense, net



    140,309



    100,611



    87,358

    Income tax expense



    (2,630)



    35,347



    30,488

    Depreciation and amortization



    198,822



    193,828



    190,393

    Income from equity method investees



    (15,187)



    (12,976)



    (11,214)

    Loss on partial extinguishment of debt



    920



    —



    —

    Goodwill impairment



    1,222,524



    —



    —

    Asset impairments and write offs



    1,895



    1,992



    7,299

    Equity-based compensation



    84,323



    60,784



    53,666

    Other non-operating (income) loss 



    (1,429)



    12,667



    39,806

    Mexico joint venture EBITDA (1)



    35,732



    29,584



    28,633

    Acquisition-related integration costs (2)



    627



    15,314



    14,687

    Other costs (3)



    12,649



    2,817



    2,198

    Adjusted EBITDA



    $      453,652



    $    530,769



    $    530,377

    Net sales



    $   6,158,767



    $ 6,035,967



    $ 5,972,365

    Net margin (4)



    (19.9 %)



    1.5 %



    1.5 %

    Adjusted EBITDA Margin



    7.4 %



    8.8 %



    8.9 %

     

    Adjusted Net Income and Adjusted EPS

    Adjusted Net Income and Adjusted diluted Earnings Per Share attributable to Petco common stockholders (Adjusted EPS) are considered non-GAAP financial measures under the SEC's rules because they exclude certain amounts included in the net income attributable to Petco common stockholders and diluted earnings per share attributable to Petco common stockholders calculated in accordance with GAAP. Management believes that Adjusted Net Income and Adjusted EPS are meaningful measures to share with investors because they facilitate comparison of the current period performance with that of the comparable prior period. In addition, Adjusted Net Income and Adjusted EPS afford investors a view of what management considers to be Petco's core earnings performance as well as the ability to make a more informed assessment of such earnings performance with that of the prior period.

     

    (in thousands, except per share amounts)



    13 Weeks Ended

    Reconciliation of Diluted EPS to Adjusted EPS



    October 28, 2023



    October 29, 2022





    Amount



    Per share



    Amount



    Per share

    Net (loss) income attributable to common stockholders / diluted EPS



    $ (1,241,137)



    $     (4.63)



    $   19,920



    $       0.07

    Add (deduct):

















    Income tax (benefit) expense



    (22,902)



    (0.09)



    4,161



    0.02

    Loss on partial extinguishment of debt



    174



    0.00



    —



    —

    Goodwill impairment



    1,222,524



    4.57



    —



    —

    Asset impairments and write offs



    1,167



    0.00



    930



    0.00

    Equity-based compensation



    18,183



    0.07



    15,775



    0.06

    Other non-operating income



    (113)



    (0.00)



    (576)



    (0.00)

    Acquisition-related integration costs (2)



    —



    —



    1,592



    0.01

    Other costs (3)



    2,556



    0.01



    (1,233)



    (0.01)

    Adjusted pre-tax (loss) income / diluted (loss) earnings per share



    $     (19,548)



    $    (0.07)



    $  40,569



    $     0.15

    Income tax (benefit) expense at 26% normalized tax rate



    (5,082)



    (0.02)



    10,548



    0.04

    Adjusted Net (Loss) Income / Adjusted EPS



    $      (14,466)



    $    (0.05)



    $  30,021



    $     0.11

     

    Free Cash Flow

    Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets. Management believes that Free Cash Flow, which measures the ability to generate additional cash from business operations, is an important financial measure for use in evaluating the company's financial performance.

    The table below reflects the calculation of Free Cash Flow for the thirteen and thirty-nine weeks ended October 28, 2023 and October 29, 2022, respectively. 

     

    (in thousands)



    13 Weeks Ended



    39 Weeks Ended





    October 28,

    2023



    October 29,

    2022



    October 28,

    2023



    October 29,

    2022

    Net cash provided by operating activities



    $   34,431



    $  109,375



    $  168,696



    $  209,463

    Cash paid for fixed assets



    (62,509)



    (75,884)



    (176,532)



    (212,074)

    Free Cash Flow



    $  (28,078)



    $    33,491



    $     (7,836)



    $     (2,611)

     

    Non-GAAP Financial Measures Footnotes

    (1)

    Mexico Joint Venture EBITDA represents 50 percent of the entity's operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes because such a presentation would not reflect the adjustments made in the calculation of Adjusted EBITDA, we include the 50 percent interest in the company's Mexico joint venture on an Adjusted EBITDA basis to ensure consistency. The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA.

     





    13 Weeks Ended

    (in thousands)



    October 28,

    2023



    October 29,

    2022

    Net income



    $      7,149



    $      5,251

    Depreciation



    6,920



    4,861

    Income tax expense



    2,470



    2,957

    Foreign currency loss (gain)



    441



    (395)

    Interest expense, net



    1,397



    1,406

    EBITDA



    $     18,377



    $     14,080

    50% of EBITDA



    $       9,189



    $       7,040





    (2)

    Acquisition-related integration costs include direct costs resulting from acquiring and integrating businesses. These include third-party professional and legal fees and other integration-related costs that would not have otherwise been incurred as part of the company's operations.

    (3)

    Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions.

    (4)

    We define net margin as net income attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/petco-health--wellness-company-inc-reports-third-quarter-earnings-301999906.html

    SOURCE Petco - Investor Relations

    Get the next $WOOF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WOOF

    DatePrice TargetRatingAnalyst
    7/19/2024$3.00 → $4.00Neutral
    Citigroup
    4/2/2024$5.00 → $1.50Buy → Underperform
    BofA Securities
    12/19/2023$3.11Hold
    Jefferies
    11/30/2023$8.00 → $3.00Outperform → Neutral
    Robert W. Baird
    11/29/2023Overweight → Equal Weight
    Wells Fargo
    9/29/2023Peer Perform
    Wolfe Research
    8/25/2023$10.00 → $7.00Outperform
    RBC Capital Mkts
    4/28/2023$10.00Hold
    Gordon Haskett
    More analyst ratings

    $WOOF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Petco to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on March 11, 2026

    SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today announced that its financial results for the fourth quarter and full year fiscal 2025 will be released after market close on Wednesday, March 11, 2026. The company will host a conference call at approximately 4:30 p.m. Eastern Time to discuss the results. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)">

    2/25/26 4:05:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Announces Completion of Refinancing and Glenn Murphy's Transition to Chairman

    SAN DIEGO, Feb. 2, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today announced the successful closing of the previously announced long-term debt refinancing and the transition of Glenn Murphy, Executive Chairman of Petco, to Chairman of the Board of Directors, effective February 1. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Joel Anderso

    2/2/26 4:15:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Announces Pricing of its $600,000,000 Offering of Senior Secured Notes

    SAN DIEGO, Jan. 22, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF) today announced the pricing of its previously announced senior secured notes offering and has agreed to issue and sell $600,000,000 in aggregate principal amount of new senior secured notes due on February 1, 2031, which will bear interest at a rate of 8.250% per annum (the "notes").  Completion of the notes offering is expected to occur on February 2, 2026 and is subject to, among other things, customary closing conditions. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco

    1/22/26 6:30:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Executive Officer Anderson Joel D

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    2/19/26 6:23:23 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 4 filed by Chief Human Resources Officer May Holly

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    2/19/26 6:22:14 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 4 filed by Chief Revenue Officer Venezia Patrick J

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    2/19/26 6:20:34 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    SEC Filings

    View All

    Petco Health and Wellness Company Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Petco Health & Wellness Company, Inc. (0001826470) (Filer)

    2/2/26 4:30:27 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Health and Wellness Company Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Petco Health & Wellness Company, Inc. (0001826470) (Filer)

    2/2/26 4:05:27 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Health and Wellness Company Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Petco Health & Wellness Company, Inc. (0001826470) (Filer)

    1/21/26 9:28:05 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Anderson Joel D bought $4,717,461 worth of shares (1,586,088 units at $2.97) (SEC Form 4)

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    4/1/25 7:14:43 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Breitner Cameron bought $2,354,325 worth of shares (750,000 units at $3.14) (SEC Form 4)

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    5/29/24 7:35:36 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Briggs Gary S bought $99,924 worth of shares (30,000 units at $3.33), increasing direct ownership by 75% to 70,085 units (SEC Form 4)

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    12/4/23 7:29:44 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup reiterated coverage on Petco Health and Wellness with a new price target

    Citigroup reiterated coverage of Petco Health and Wellness with a rating of Neutral and set a new price target of $4.00 from $3.00 previously

    7/19/24 8:30:14 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Health and Wellness downgraded by BofA Securities with a new price target

    BofA Securities downgraded Petco Health and Wellness from Buy to Underperform and set a new price target of $1.50 from $5.00 previously

    4/2/24 7:46:18 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Jefferies initiated coverage on Petco Health and Wellness with a new price target

    Jefferies initiated coverage of Petco Health and Wellness with a rating of Hold and set a new price target of $3.11

    12/19/23 6:54:34 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Leadership Updates

    Live Leadership Updates

    View All

    Petco Announces Completion of Refinancing and Glenn Murphy's Transition to Chairman

    SAN DIEGO, Feb. 2, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today announced the successful closing of the previously announced long-term debt refinancing and the transition of Glenn Murphy, Executive Chairman of Petco, to Chairman of the Board of Directors, effective February 1. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Joel Anderso

    2/2/26 4:15:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Leslie's Announces Seasoned Retail Executive Amy College as Chief Merchandising and Supply Chain Officer

    PHOENIX, July 15, 2025 (GLOBE NEWSWIRE) -- Leslie's, Inc. (NASDAQ:LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, today announced appointment of Amy College as the company's new Chief Merchandising and Supply Chain Officer effective July 20, 2025. In addition to merchandising, inventory, supply chain, logistics and manufacturing, Ms. College will be responsible for the company's digital marketplace business. In conjunction with Ms. College's appointment, Moyo LaBode, the company's outgoing Chief Merchandising and Supply Chain Officer has left Leslie's, effective July 15, 202

    7/15/25 4:10:43 PM ET
    $LESL
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    PETCO STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENT OF THREE PROVEN EXECUTIVES

    Sabrina Simmons Appointed Chief Financial Officer Michael Romanko Appointed Chief Customer and Product Officer Jack Stout Appointed Chief Merchandising Officer SAN DIEGO, Feb. 18, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), today announced the appointment of three new leaders to Petco's executive team to support accelerated operational improvement and position the business for a faster return to profitable growth. Sabrina Simmons, former Chief Financial Officer at Gap, Inc., has been named Chief Financial Officer, effective February 17.Michael

    2/18/25 4:10:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Financials

    Live finance-specific insights

    View All

    Petco to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on March 11, 2026

    SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today announced that its financial results for the fourth quarter and full year fiscal 2025 will be released after market close on Wednesday, March 11, 2026. The company will host a conference call at approximately 4:30 p.m. Eastern Time to discuss the results. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)">

    2/25/26 4:05:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Reports Third Quarter 2025 Financial Results

    Upwardly Revises Fiscal 2025 Earnings Outlook* SAN DIEGO, Nov. 25, 2025 /PRNewswire/ -- Petco (NASDAQ:WOOF) today announced its third quarter 2025 financial results. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Q3 2025 Overview Net sales of $1.5 billion decreased 3.1% year over year in line with the company's third quarter outlookComparable sales decreased 2.2% year over yearGross profit margin expanded approximately 75 ba

    11/25/25 4:05:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco to Host Third Quarter 2025 Earnings Conference Call on Nov. 25, 2025

    SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- Petco (NASDAQ:WOOF), today announced that its financial results for the third quarter fiscal 2025 will be released after market close on Tuesday, Nov. 25, 2025. The company will host a conference call at 4:30 p.m. Eastern time to discuss the results. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> A live webcast of the conference call will be available on the company's Investor Relatio

    11/11/25 4:05:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Petco Health and Wellness Company Inc. (Amendment)

    SC 13G/A - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

    2/14/24 12:55:28 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    SEC Form SC 13G/A filed by Petco Health and Wellness Company Inc. (Amendment)

    SC 13G/A - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

    2/14/24 6:00:20 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    SEC Form SC 13G filed by Petco Health and Wellness Company Inc.

    SC 13G - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

    2/14/22 4:43:20 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary